Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Hanbali, Amr
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
I
Abdrabou AKotb
,
Sharif FAl
,
Fakih REl
,
Zahrani HAl
,
Yamany RAl
,
Saleh M
,
AlHayli S
,
Somali ZAl
,
Alotaibi A
,
AlShaibani AF
, et al.
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.
Ann Saudi Med. 2024;44(2):93-103.
PubMed
Google Scholar
Kotb A
,
Alzahrani H
,
AlAhmari A
,
AlHayli S
,
Shaheen M
,
Chaudhri N
,
Alsharif F
,
Hanbali A
,
Alfraih F
,
AlShaibani AF
, et al.
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Cytotherapy. 2023.
PubMed
Google Scholar
M
Alfraih F
,
Absi A
,
Abuhaleeqa M
,
Alghamdi K
,
Alhuraiji A
,
Al-Khabori M
,
Al-Shaibani Z
,
Alzahrani M
,
Cherif H
,
Eldadah S
, et al.
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group.
Cancer Rep (Hoboken). 2023:e1931.
PubMed
Google Scholar
O
Solaiman OM
,
Elhassan T
,
Fakih RE
,
Mannan A
,
Alduhailib Z
,
Mahdali AA
,
Alzahrani H
,
Jamil M
,
Chaudhri N
,
Elhazmi A
, et al.
Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
Hematol Oncol Stem Cell Ther. 2024;17(2):110-119.
PubMed
Google Scholar
R
Yang EH
,
Muhsen IN
,
Samarkandi H
,
Fakih REl
,
Aljurf M
,
Hanbali A
.
Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases.
Hematol Oncol Stem Cell Ther. 2023;17(1):4-12.
PubMed
Google Scholar